GLUN
Linfomas
Publikationen (95) Publikationen, an denen Forscher/innen teilgenommen haben
2024
-
Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol
Frontiers in Nutrition, Vol. 11
-
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)
Blood cancer discovery, Vol. 5, Núm. 1, pp. 21-33
-
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Blood cancer discovery, Vol. 5, Núm. 3, pp. 146-152
2023
-
Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation
Blood, Vol. 141, Núm. 9, pp. 1047-1059
-
Antifibrogenic and apoptotic effects of Ocoxin in cultured rat hepatic stellate cells
Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 881-890
-
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Cancers, Vol. 15, Núm. 5
-
Chronic docosahexaenoic acid supplementation improves metabolic plasticity in subcutaneous adipose tissue of aged obese female mice
Journal of Nutritional Biochemistry, Vol. 111
-
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries
Frontiers in Medicine, Vol. 10
-
Differential remodeling of subcutaneous white and interscapular brown adipose tissue by long-term exercise training in aged obese female mice
Journal of Physiology and Biochemistry, Vol. 79, Núm. 2, pp. 451-465
-
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Nature Communications, Vol. 14, Núm. 1
-
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation
Disease Markers, Vol. 2023
-
Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients with Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis
HemaSphere
-
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study
eClinicalMedicine, Vol. 63
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
-
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Journal of Clinical Medicine, Vol. 12, Núm. 20
-
Regulation and role of the PP2A-B56 holoenzyme family in cancer
Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1878, Núm. 5
-
Set Protein Is Involved in FLT3 Membrane Trafficking
Cancers, Vol. 15, Núm. 8
-
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis
Blood, Vol. 141, Núm. 21, pp. 2615-2628
-
Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model
Cells, Vol. 12, Núm. 1
-
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
Journal for immunotherapy of cancer, Vol. 11, Núm. 2